HealthTree

Your Feed

Filter by

See content from

Back to the latest

What's Happening with Medicare Advantage and Medigap?

Jun 06, 2023

01:00PM - 02:00PM EDT

Watch Recording

Playlist: ASCO 2023

Results of Bispecific Antibody Combination in Advanced Myeloma | Yael Cohen, MD | ASCO 2023

Video details & playlist

Playlist: ASCO 2023

Exciting Advances in Myeloma Treatment | Timothy Schmidt, MD | ASCO 2023

Video details & playlist

ASCO 2023: The New T-Charged CAR on the Block: PHE885

Posted by

HealthTree

ASCO 2023: The New T-Charged CAR on the Block: PHE885 image

Read article

The Importance Of Glucose Levels And Cancer Cells

Posted by

HealthTree

The Importance Of Glucose Levels And Cancer Cells image

Read article

Results for Briquilimab, a Well Tolerated Conditioning Agent Used Before Transplant

Posted by

HealthTree

Results for Briquilimab, a Well Tolerated Conditioning Agent Used Before Transplant image

Read article

$Thumbnail for Bispecific Antibody Therapy in Relapsed/Refractory Myeloma | Meera Mohan, MD, MS, FACP | ASCO 2023$

Playlist: ASCO 2023

Bispecific Antibody Therapy in Relapsed/Refractory Myeloma | Meera Mohan, MD, MS, FACP | ASCO 2023

Video details & playlist

ASCO 2023: A Maintenance Regimen for High-Risk Myeloma

Posted by

HealthTree

ASCO 2023: A Maintenance Regimen for High-Risk Myeloma image

Read article

ASCO 2023: A New Induction Therapy for Newly Diagnosed Myeloma

Posted by

HealthTree

ASCO 2023: A New Induction Therapy for Newly Diagnosed Myeloma image

Read article

ASCO 2023: Benefits of Exercise for Multiple Myeloma Patients

The Role of Lifestyle on MGUS Progression | Betsy O’Donnell, MD | ASCO 2023

Video details & playlist

Playlist: Precursor Conditions (2020)

(Guest Lecture): June 2023 - The Role of Lifestyle on MGUS Progression with Betsy O’Donnell, MD | ASCO 2023

Video details & playlist

Playlist: ASCO 2023

Advancements in AML & MDS: Genetic Sequencing & Immune Therapies | David Swoboda, MD | ASCO 2023

Video details & playlist

Playlist: ASCO 2023

Advancements in AML & MDS: Genetic Sequencing & Immune Therapies | David Swoboda, MD | ASCO 2023

Video details & playlist

$Thumbnail for LINKER-MM1 Study: Linvoseltamab (REGN5458) in Relapsed/Refractory Myeloma | Hans Lee, MD | ASCO 2023$

Playlist: ASCO 2023

LINKER-MM1 Study: Linvoseltamab (REGN5458) in Relapsed/Refractory Myeloma | Hans Lee, MD | ASCO 2023

Video details & playlist

Qunbin

Multiple Myeloma Discussion • June 3, 2023

Understanding Treatment Outcomes: Helpful Resource

AI-generated title

Measuring Treatment Response for Myeloma: https://www.lls.org/myeloma/treatment/treatment-outcomes With the current advances in treatment and supportive care, survival rates for myeloma patients have improved significantly in the last decades. It is not unusual for myeloma patients to live for 10 years or longer after diagnosis. Outcomes are influenced by a series of patient-specific factors, including disease stage, chromosome abnormalities, age, and the presence of other medical problems. Patients should discuss their own potential outcomes with their doctors.

Multiple Myeloma | Treatment Outcomes for Multiple Myeloma | LLS

Your doctor must monitor your response to treatment for myeloma. By measuring your progress, your doctor can see whether changes to your treatment are needed.

https://www.lls.org/myeloma/treatment/treatment-outcomes

Understanding the 2023 ASCO Annual Meeting: What Do Patients Need to Know?

ASCO 2023 Highlights To Look Forward To | Saad Usmani, MD | ASCO 2023

Video details & playlist

Understanding Patient Perspectives Toward Participation in Multiple Myeloma Clinical Trials

Posted by

HealthTree

Understanding Patient Perspectives Toward Participation in Multiple Myeloma Clinical Trials image

Read article

HealthTree Coach Creates a Myeloma Game Plan

Posted by

HealthTree

Read article

A New Bi-Specific Antibody Therapy On The Horizon: ABBV-383

Posted by

HealthTree

A New Bi-Specific Antibody Therapy On The Horizon: ABBV-383 image

Read article

How Does MDS Turn into AML?

Posted by

HealthTree

Read article

Negotiating Medical and Other Debt

Posted by

HealthTree

Negotiating Medical and Other Debt image

Read article

SiemVeldboer

Multiple Myeloma Discussion • May 31, 2023

Experiences With Talquetamab Trial?

AI-generated title

Has anyone had experience with talquetamab? It is in phase 2 of trial and my oncologist/hematologist has recommended it. I have relapsed and am now in a so called wait and see intermediate phase. As soon as lab results or CRAB criteria require treatment I will be put on the trial.